Abstract

This research focuses on the development, evaluation, and optimization of Ziprasidone Hydrochloride (ZH) capsules, a potent antipsychotic used in managing psychiatric disorders. The process includes formulation design, evaluation of quality attributes, and optimization to improve drug delivery performance. The formulation stage involves selecting appropriate excipients and determining optimal ratios, while the evaluation phase involves rigorous analysis of parameters like weight variation, content uniformity, hardness, disintegration time, and dissolution profiles. The optimization phase uses statistical tools and experimental design methodologies to identify optimal formulation parameters.

Keywords

• Ziprasidone Hydrochloride,
• Formulation,
• Evaluation,
• Optimization,
• Capsules

References

• • Hörter, D., & Dressman, J. B. (1997). Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Advanced Drug Delivery Reviews, 25(1), 3-14.
• • Swarbrick, J. (2013). Encyclopedia of Pharmaceutical Technology: Volume 6. CRC press.
• • Reynolds, J. E. (1982). Martindale: the extra pharmacopoeia. London, UK; The Pharmaceutical Press.
• • Deshmukh, S. S., Potnis, V. V., MAHAPARALE, P., & KUTE, A. (2006). Development of dissolution medium for ziprasidone HCl. The Indian pharmacist, 5(47), 79-80.
• • Goodman, L. S. (1996). Goodman and Gilman's the pharmacological basis of therapeutics (Vol. 1549, pp. 1361-1373). New York: McGraw-Hill.
• • Schatzberg, A. F., & Nemeroff, C. B. (Eds.). (2017). The American psychiatric association publishing textbook of psychopharmacology. American Psychiatric Pub.
• • Brayfield, A. (2017). Martindale: the complete drug reference. Pharmaceutical Press; 1036-7.
• • Davis, R., & Markham, A. (1997). Ziprasidone. CNS drugs, 8(2), 153-159.
• • Urban, A. E., & Cubała, W. J. (2017). Terapia monitorowana atypowymi lekami przeciwpsychotycznymi. Psychiatr. Pol, 51(6), 1059-1077.
• • Skoog, D. A., West, D. M., Holler, F. J., & Crouch, S. R. (2013). Fundamentals of analytical chemistry. Cengage learning.
• • Sharma, Y. R. (2007). Elementary organic spectroscopy. S. Chand Publishing.
• • Lachman, L., & Schwartz, J. B. (1990). Pharmaceutical Dosage Forms--tablets: Tablets. Informa Healthcare.
• • Anderson, M. J., & Whitcomb, P. J. (2017). DOE simplified: practical tools for effective experimentation. CRC press.
• • Costa, P., & Lobo, J. M. S. (2001). Modeling and comparison of dissolution profiles. European journal of pharmaceutical sciences, 13(2), 123-133.
• • Brahmankar, D. M., & Jaiswal, S. B. (1995). Biopharmaceutics and pharmacokinetics-A Treatise Vallabh Prakashan. New Delhi.

This work is licensed under a Creative Commons Attribution 4.0 International License.